M. Feigen

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Presented at the 13th Asia Pacific Cancer Conference, Penang, Malaysia, November 17–20, 1996 and also presented at the Royal Australasian College of Radiologists 47th Annual General and Scientific Meeting, Perth, Western Australia, October 5–9th, 1996. Accepted for presentation at the American Radium Society 79th Annual Meeting, New York, N.Y., April 30–May 4, 1997.1

John D Kiffer, Salvatore U. Berlangieri, Andrew M. Scott et al. · Lung Cancer · 1998 · 189 citations

Medicine, Oncology, Radiology +17

Assessing the impact of FDG-PET in the management of anal cancer

Brandon Nguyen, Daryl Lim Joon, Vincent Khoo et al. · Radiotherapy and Oncology · 2008 · 119 citations

Medicine, Oncology, Surgical Oncology +5

Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial

Madeleine King, Emma Link, Timothy J. Whelan et al. · The Lancet Oncology · 2020 · 52 citations

Medicine, Oncology, Radiation Oncology +14

Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma

S. T. Lee, Mazen A. Ghanem, Rebecca Herbertson et al. · Molecular Imaging and Biology · 2009 · 40 citations

Medicine, Oncology, Radiology +16

The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer

Daisy Mak, Daryl Lim Joon, Michael Chao et al. · Radiotherapy and Oncology · 2010 · 31 citations

Medicine, Oncology, Surgery +16